PMEL and melanoma: In an adoptive T cell transfer (ACT) model, frequencies of gp100 specific luciferase expressing pmel-1 T cells were markedly increased in gp100 expressing melanoma lesions after treatment with vemurafenib (32) and this was associated with improved tumor response compared to either vemurafenib or ACT alone.